Mesa Laboratories Inc

Mesa Laboratories Inc

Mesa Laboratories, Inc. (MLAB) is a small-cap company providing specialised instruments, consumables and related services used to test, monitor and validate equipment and environments across healthcare, life‑sciences and industrial settings. With a market capitalisation around $434M, it operates in niche segments where product reliability, regulatory compliance and recurring consumables can contribute to steady revenue streams. Investors should note the firm's exposure to cyclical capital spending, regulatory cycles and competition from larger instrument manufacturers. As a smaller company, Mesa can offer growth potential but also tends to show higher volatility and thinner trading liquidity than larger peers. Financial performance will depend on product adoption, service contracts and geographic diversification. This summary is for general educational purposes only, not personalised investment advice; values can rise and fall and past performance is not a guide to the future. Consider your risk tolerance and consult a qualified adviser before investing.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying Mesa Laboratories' stock, predicting it could rise significantly in value.

Above Average

Financial Health

Mesa Laboratories Inc shows strong revenue and profit generation, supported by good cash flow indicators.

Below Average

Dividend

Mesa Laboratories Inc's dividend yield of 0.94% is relatively low, making it less attractive for dividend-focused investors. If you invested $1000 you would be paid $9.40 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring MLAB

Pharma Onshoring Boom: Investment Risk Considerations

Pharma Onshoring Boom: Investment Risk Considerations

AstraZeneca is building a major new manufacturing plant in the U.S., responding to policy pressures for domestic production. This signals a broader trend of onshoring pharmaceutical manufacturing, creating opportunities for companies that build and equip these advanced facilities.

Published: October 10, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Niche instrument exposure

Specialised products and consumables can create recurring sales and pricing power, though demand can fluctuate with customer capital budgets.

Quality and compliance

Products used in regulated environments benefit from high reliability and certification, but regulatory shifts can materially affect demand and costs.

🌍

Small‑cap growth potential

A market cap around $434M offers potential upside if the company executes, balanced by higher volatility and lower liquidity than large caps.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

AME

Ametek Inc.

Ametek is a leading global manufacturer of electronic instruments and electromechanical devices with operations in the United States and across the world.

AIT

Applied Industrial Technologies Inc

Distributes industrial and mechanical products to industrial customers in North America.

AOS

AO Smith Corp.

AO Smith Corp. is a global manufacturer of water heaters and boilers for residential and commercial applications.

Frequently asked questions